These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14299158)

  • 41. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF PERIPHERAL ARTERIAL CIRCULATORY DISORDERS].
    RATSCHOW M
    Wien Klin Wochenschr; 1964 Apr; 76():233-8. PubMed ID: 14194768
    [No Abstract]   [Full Text] [Related]  

  • 42. [DIISOPROPYLAMMONIUM DICHLOROETHANOATE (DIEDI). TREATMENT OF PERIPHERAL ARTERIOPATHIES OF OLD AGE].
    MOCCHI N; MALUSARDI R
    Gazz Med Ital; 1963 Oct; 122():310-5. PubMed ID: 14095912
    [No Abstract]   [Full Text] [Related]  

  • 43. [ON PERIOSTEAL CHANGES IN PERIPHERAL OBLITERATING ARTERIAL CIRCULATORY DISORDERS].
    SCHNEIDER VM; SCHNEPPER E; HILLENBRAND HJ
    Fortschr Geb Rontgenstr Nuklearmed; 1963 Aug; 99():228-34. PubMed ID: 14047700
    [No Abstract]   [Full Text] [Related]  

  • 44. ARTERIAL DISEASE IN JAPAN.
    ISHIKAWA K
    Jpn Heart J; 1964 May; 5():199-200. PubMed ID: 14170435
    [No Abstract]   [Full Text] [Related]  

  • 45. [OUR THERAPEUTIC RESULTS WITH THE SYNCARDON MACHINE].
    BUGAR MESZAROS K; KUSZTOS D
    Orv Hetil; 1964 Dec; 105():2467-70. PubMed ID: 14231357
    [No Abstract]   [Full Text] [Related]  

  • 46. [ALTERATIONS OF CUTANEOUS AND MUSCULAR SENSITIVITY IN CHRONIC OBLITERATING ARTERIOPATHIES OF THE LOWER LIMBS AND THEIR IMPORTANCE IN THE DETERMINATION OF INTERMITTENT CLAUDICATION].
    ARCANGELI P; CORRADI F; D AYALAVALVA G
    Rass Neurol Veg; 1964 Aug; 18():167-238. PubMed ID: 14204209
    [No Abstract]   [Full Text] [Related]  

  • 47. An evaluation of nicotinyl salicylic acid in arteriosclerosis obliterans.
    KROPF W
    J Mt Sinai Hosp N Y; 1956; 23(6):832-5. PubMed ID: 13377153
    [No Abstract]   [Full Text] [Related]  

  • 48. [TOBACCO AND OTHER ETIOLOGICAL FACTORS IN OBLITERATING ARTERIOPATHY OF THE LOWER LIMBS. RESULTS OF A RETROSPECTIVE STUDY].
    SCHWARTZ D; LELLOUCH J; ANGUERA G; RICHARD JL
    J Atheroscler Res; 1965; 5(3):302-10. PubMed ID: 14290293
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 50. [ARTERIAL OCCLUSION DISEASES AND THE CAPILLARY PICTURE IN REST AND AFTER STRESS].
    JACOBY H
    Med Welt; 1964 Apr; 14():768-74. PubMed ID: 14198048
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 52. [Impulse barotherapy of obliterating diseases of the arteries of the extremities].
    Karapovskiĭ MI
    Klin Khir (1962); 1968 Apr; 4():56-60. PubMed ID: 5740037
    [No Abstract]   [Full Text] [Related]  

  • 53. Peripheral arterial insufficiency. An epidemiological study of 2,243 hospital admissions caused by arteriosclerosis obliterans, diabetes mellitus, thrombangitis obliterans and arterial embolism.
    Tibell B
    Acta Orthop Scand Suppl; 1971; 139():1-54. PubMed ID: 5291650
    [No Abstract]   [Full Text] [Related]  

  • 54. [HISTOLOGICAL ASPECTS OF OBLITERATED SYNTHETIC ARTERIAL PROSTHESES].
    FONTAINE JL; BOLLACK C; FONTAINE R
    Lyon Chir; 1964 May; 60():334-46. PubMed ID: 14165987
    [No Abstract]   [Full Text] [Related]  

  • 55. [Descriptions of peripheral chronic obliterating arteriopathy based on parallel and comparative studies of the clinical aspects, arteriographical and histopathological data and conditions of blood coagulability].
    TAGLIACOZZO S; TONELLI L
    Arch De Vecchi Anat Patol; 1956 Jun; 24(2):443-562. PubMed ID: 13363590
    [No Abstract]   [Full Text] [Related]  

  • 56. [CLINICAL OBSERVATIONS ON THE USE OF GRISEOFULVIN IN CHRONIC PERIPHERAL OBLITERATING ARTERY DISEASES].
    SFORZA F; MOSSA L
    Rass Med Sarda; 1964; 67():555-78. PubMed ID: 14269114
    [No Abstract]   [Full Text] [Related]  

  • 57. [PERIPHERAL CIRCULATION TIME IN CHRONIC OBLITERATING ARTERIAL DISEASES OF LOWER LIMBS DETERMINED WITH THE RADIOISOTOPE METHOD].
    TAROLO GL
    Minerva Cardioangiol; 1964 Dec; 12():508-14. PubMed ID: 14269032
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative results of reconstructive surgery of the arteries of the femoro-popliteal-tibial segment in patients with obliterating atherosclerosis and thromboangiitis].
    Gervaziev VB; Khorev NG; Bykov VM; Fust VI; Lukovskiĭ NK; Chilikidi KIu
    Klin Khir (1962); 1989; (7):7-9. PubMed ID: 2796160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [EXPERIENCES WITH ARTERIAL SOLCOSERYL THERAPY IN PERIPHERAL CIRCULATORY DISORDERS].
    KAPPERT A
    Med Welt; 1965 Apr; 15():752-4. PubMed ID: 14271434
    [No Abstract]   [Full Text] [Related]  

  • 60. [EVALUATION OF THE THERAPEUTIC ACTION OF GRISEOFULVIN IN CHRONIC OBLITERATING ARTERY DISEASES OF THE LEGS].
    DIGIOVANNI V; DINEGRO GC; BIGGIO P
    Rass Med Sarda; 1964; 67():541-54. PubMed ID: 14269113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.